ORIC Oric Pharmaceuticals, Inc.

NEUTRAL Impact: 3/10 Institutional Cluster
Horizon weeks Processed 2d 6h ago
Institutional cluster: 4 buyers, 0 sellers (bullish)

Executive Summary

Four mega-passive institutional investors (Vanguard, BlackRock, State Street, Morgan Stanley) collectively added $63.2M in ORIC shares during Q3 2025, increasing aggregate holdings to $156.9M. This is a passive index rebalancing signal, not an active investment thesis — the buying is driven by index inclusion or weighting adjustments, not fundamental conviction.

Key Financial Metrics

Direction
accumulating
Buy Value
$156.9M
Net Flow
$63.2M

Institutional Positions

Net institutional flow: $63.2M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
Vanguard ADD +48.8% $55.8M $24.1M
BlackRock ADD +29.4% $63.3M $21.9M
State Street ADD +47.3% $28.8M $12.3M
Morgan Stanley ADD +88.8% $8.9M $4.9M

Actionable Insight

The buying is entirely from mega-passive index funds, likely reflecting ORIC's inclusion in or increased weighting within broad market indices. This provides no fundamental signal about the company's pipeline or prospects. Monitor upcoming clinical catalysts and earnings for real directional cues — the passive accumulation is noise, not conviction.

Key Facts

  • 4 mega-passive funds added $63.2M net to ORIC in Q3 2025
  • Total institutional holdings in cluster rose to $156.9M
  • No active managers, hedge funds, or family offices participated
  • Vanguard added 48.8% ($24.1M), BlackRock added 29.4% ($21.9M), State Street added 47.3% ($12.3M), Morgan Stanley added 88.8% ($4.9M)
  • Zero sellers in the cluster

Financial Impact

4 passive funds accumulated $63.2M in ORIC shares during Q3 2025, bringing total cluster holdings to $156.9M

institutional ownershipfloat

Risk Factors

  • Passive buying provides no fundamental validation of ORIC's pipeline or commercial prospects
  • Historical reports on ORIC have shown poor predictive accuracy (avg T+20 return -9.27%, 33% win rate)
  • Passive flows can reverse if index composition changes

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (22 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-ORIC-2025-Q3
3 reports for ORIC
Performance horizon
Filters
Rows
Reports for ORIC — sortable, filterable
Type Now
Jun 11, 2026
2d ago
Institutional Cluster
NEUTRAL ★ 3/10
$7.80 awaiting T+20awaiting T+20
May 4, 2026
5w ago
8-K
MIXED ★ 4/10
$9.57 $7.62▼ −20.38%▼ −25.33%
Apr 3, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$8.91 $9.63▲ +8.08%▼ −0.90%
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (44h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access